|Articles|November 1, 2012
- Pharmaceutical Executive-11-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2012
Pharm Exec's 2013 Pipeline Report
Advertisement
Articles in this issue
over 13 years ago
Europe's Trust Gapover 13 years ago
Who Pays for Specialty Medicines?over 13 years ago
OTC Crunch Time in Californiaover 13 years ago
Prix Galien: Night at the Museumover 13 years ago
Real World Insightsover 13 years ago
Simple Questions for Spainover 13 years ago
Market Access Roadmapover 13 years ago
Pharm Exec's 2013 Pipeline Reportover 13 years ago
Country Report: Czech RepublicAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
2
Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma
3
The New Healthy Aging Imperative and What It Means for Pharma
4
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
5